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Triglyceride to HDL cholesterol ratio and risk for 
gestational diabetes and birth of a large-for-gestational-age 
newborn 
 
 
Abstract 
Background: Using oral glucose for glucose challenge test (GCT) and glucose tolerance 
test (GTT) is problematic, especially in early pregnancy when the pregnant woman is 
experiencing gastrointestinal complications. This research seeks to investigate the 
relationship between the ratio of Triglyceride (TG) to high-density lipoprotein cholesterol 
(HDL-C) and the risk of gestational diabetes and large for gestational age (LGA) fetus for 
suggesting a more appropriate index for diagnosis of gestational diabetes. 
Methods: The present cross-sectional study investigated pregnant women visiting the 
Perinatal Clinic of Ayatollah Rouhani Hospital in Babol for prenatal care from September 
2015-2016. The GCT was performed on these pregnant women at 24-28 weeks as a 
screening test and their lipid profile, including HDL-C and TG, was simultaneously 
assessed after eight to 14 hours of fasting. 
Results: Significant differences were observed between women with and without 
gestational diabetes in terms of mean triglyceride, HDL, LDL/HDL ratio, triglyceride/LDL 
ratio and triglyceride/HDL ratio. The cut-off point of TG/HDL in the GTT was 4.254 with 
a sensitivity of 79.07% and specificity of 78%. 
Conclusions: According to the results obtained, lipid profile can help predict the risk of 
gestational diabetes, especially TG/HDL ratio that has a high sensitivity to diagnose 
gestational diabetes, while, lipid indices could not predict birth of a LGA neonate. 
Keywords: Gestational Diabetes, Triglyceride, Cholesterol, Triglyceride/HDL Ratio, Risk 
Factors, Large for Gestational Age 
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Gestational diabetes mellitus (GDM) refers to any degree of glucose intolerance 
diagnosed or started during pregnancy (1). The prevalence of GDM has increased in recent 
years throughout the world, as well as Iran (2). As suggested, many factors play a role in 
the incidence of gestational diabetes, including diagnostic method, mother’s ethnicity, 
body composition, age of menstruation onset, family history of diabetes, obesity, and 
history of neonatal death (3, 4). This common metabolic pregnancy disorder is associated 
with many maternal and fetal complications (preeclampsia, premature rupture of 
membranes, preterm delivery, increased risk of cesarean section, hydramnios, fetal 
macrosomia and low birth weight) (5, 6). Furthermore, more than half of women with 
gestational diabetes develop diabetes within 20 years (7). Therefore, diagnosis of 
gestational diabetes is very important in reducing maternal and fetal complications. 
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Glucose challenge test (GCT) is routinely tested for all 
pregnant women and at-risk patients take oral glucose 
tolerance test (OGTT) as well for screening of GDM, but 
these tests are associated with several problems, such as 
patients’ intolerance after drinking the glucose solution, 
vomiting, and gastrointestinal complications, research is 
continued to find a substitute test (8). Along with several 
biological changes in pregnancy, lipid metabolism and serum 
lipid profile alters, as well (9), supposed to be not only due 
to the changes in body fat but also due to other molecular 
etiologies, including inflammation and insulin resistance 
(10).  
For example reduced high-density lipoprotein cholesterol 
(HDL-C) (9) and triglyceride (TG)/HDL-C ratio (11) have 
been associated with insulin-resistance. As insulin resistance 
is the principal physiopathology of GDM (3, 12), different 
lipid ratios have been used to predict the risk of GDM (13). 
Given the importance of the early diagnosis of GDM and 
inadequate information about universal or case-specific 
screening tests for GDM, and considering the changes in 
lipid metabolism in patients with GDM and the potential 
pathophysiology of this disease, conducting further studies 
such as the present one appears necessary. 
Although, the primary goal of this lipid alterations in 
pregnancy is nutritional supply to the fetus, these changes 
have been associated with several neonatal adverse 
outcomes, like pre-eclampsia (14). Previous studies have 
also shown a significant and positive correlation between 
mother’s fasting TG levels in late pregnancy and neonatal 
birth weight, irrespective of the mother’s glucose level or 
weight (15).  
As birth of large for gestational age (LGA) neonates 
remains a major problem in GDM with a prevalence of about 
30% in diabetic women (16), despite the improvements in 
prenatal care and the early diagnosis and proper treatment of 
diabetes, investigating an index for prediction of this 
neonatal complication is of great value. As previously 
suggested, hypertriglyceridemia (17) and low HDL-C (18) 
are associated with LGA, therefore, we hypothesized in the 
present research that TG/HDL-C ratio could be an 
appropriate index for prediction of LGA.  
Furthermore, as explained above, TG and HDL-C have 
been separately associated with the risk of GDM, but the 
association of TG/HDL-C ratio has not been studied, as far 
as we are concerned. Therefore, the present study aimed to 
investigate the association of TG/HDL-C ratio with GDM 
and LGA to help diagnose or predict these conditions and 
prevent their complications. 
 
 
Methods 
The present cross-sectional study was conducted on 
pregnant women visiting the Perinatal Clinic of Ayatollah 
Rouhani Hospital in Babol, who referred for prenatal care to 
this center in September 2015-2016. The study was approved 
by Ethics Committee of Babol University of Medical 
Sciences. Thus at first, the study objectives were explained 
to the eligible women and after signing the written informed 
consent, the checklist of demographic details was completed 
for the patients. The study inclusion criteria consisted of 
having a singleton pregnancy, being in the second trimester 
when first receiving perinatal care, gestational age of ≥ 36 
weeks at delivery, mother’s age between 18 and 35 and 
complete medical records. 
 The exclusion criteria were having type I and II diabetes, 
documented hyperlipidemia before pregnancy, documented 
hypertension, cardiovascular diseases, and metabolic 
syndrome before pregnancy and history of severe systemic 
diseases such as liver cirrhosis, chronic renal failure, severe 
anemia, autoimmune diseases and untreated endocrine 
disorders. The sample size was calculated at 84 at the group 
with diabetes, considering α=0.05 and 1-β=0.8, based on the 
study by Wang et al. (13) and 240 in the group without 
diabetes, thus, considering the chance of lost to follow-up, 
100 cases and 300 controls were considered as the final 
sample size.  
GDM was diagnosed in accordance with the latest 
revision of American Diabetes Association’s guidelines (19), 
and GCT screening test was tested for all the included 
pregnant women at 24-28 weeks of gestation and their 
plasma glucose was measured one hour after the oral intake 
of 50 grams of glucose, irrespective of the timing of the last 
meal. If plasma glucose was ≥140 mg/dl one hour later, the 
patient was suspected of diabetes and GTT was tested two 
weeks later using 100 grams of oral glucose. The cut-off 
point used was based on Carpenter variables for diagnosis of 
GDM; GDM was diagnosed when two or more of the 
following were positive: fasting blood sugar >95mg/dl, 
blood sugar >180 mg/dl one hour after the oral intake of 100 
grams of glucose, blood sugar >155 mg/dl two hours later 
and blood sugar >140mg/dl three hours later (20). HbA1C 
was also measured in women diagnosed with gestational 
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diabetes. The diabetic women were given advice on physical 
exercise, diabetic diet, and regular blood sugar monitoring, 
and insulin therapy was initiated in them if they had 
unfavorable blood sugar levels.   
The subjects’ lipid profile, including HDL-C (first 
trimester 40-78, second trimester 52-87, third trimester 48-
87) and TG (first trimester 40-159, second trimester 75-382, 
third trimester 131-453, was checked simultaneously after 
eight to 14 hours of fasting (definition for pregnant women: 
hypertriglyceridemia means TG ≥ 1.7 mmol/L or 150 mg/dl 
and low HDL means HDL-C < 1 mmol/L or 80 mg/dl). All 
the serum parameters were measured at Ayatollah Rouhani 
Hospital Laboratory in Babol, by Ziestchem Diagnostic 
Tehran; according to the glucose kit, the kit’s sensitivity was 
5 mg/dL, cv<2%, and r=0.966. According to the manufacturer’s 
instructions, HDL’s kit had a sensitivity of 1 mg/dL, cv<4%, 
and r=0.995, and that of TG’s kit had a sensitivity of 5 
mg/dL, cv<2%, and r=0.993. Participants were followed-up 
until child birth and neonatal data, including weight and 
gender, were recorded upon childbirth. An infant with a birth 
weight in the high 90
th
 percentile was considered as LGA 
(21). The data completed for all pregnant women with and 
without GDM included BMI before pregnancy, gestational 
age and weight at GCT, gestational age and weight at 
childbirth, weight gain during pregnancy, blood sugar one 
hour after oral intake of 50 grams of glucose, HbA1C level, 
lipid profile (TG/HDL-C ratio) and blood sugar one, two and 
three hours after glucose intake and while fasting. 
 The normal distribution of the data was assessed using 
K-S test. Chi-square test and t-test were used for comparing 
the quantitative and qualitative variables and logistic 
regression test was used for multivariate analysis. After 
adjusting the groups in terms of the mother's age and BMI, 
the relationship between birth weight and TG/HDL-C ratio 
and other variables was assessed, and the risk factor for LGA 
was determined through statistical tests. The data obtained 
were analyzed in SPSS-22 and CATmaker software was also 
used to assess the accuracy of the diagnosis by finding the 
sensitivity, specificity, positive and negative predictive 
values and positive and negative likelihood ratios. P<0.05 
was considered statistically significant.  
 
 
Results 
Comparison of the mean values or ratios of the 
demographic variables between the two groups of pregnant 
women with and without GDM based on the GTT is shown 
in table 1.  
 
Table 1.The maternal and neonatal characteristics in the 
groups with and without gestational diabetes 
 
P value GDM 
Mean±SD 
With GDM* 
Mean±SD 
Variables 
0.001 0.74±37.77 1.12±38.55 Gestational Age 
(Week) 
 
 
0.002 
 
 
26 
60 
 
 
38 
212 
Gestational Age 
(Week)  
37> 
37< 
0.001 30.49±4.00 4.87±27.33 Age(Years) 
 
 
0.001 
 
42 
43 
1 
 
184 
66 
- 
Age(Years)  
20-29 
30-34 
>35 
0.001 28.5±3.73 25.72± 4.33 BMI(Kg/m2) 
 
 
0.001 
 
 
- 
17 
69 
 
9 
117 
124 
BMI(Kg/m2)  
<18.5 
18.5-24.9 
>25 
0.002 0.96± 0.77 0.69± 0.64 Parity 
0.017 2.23±1.03 1.95± 0.90 Gravidity 
 
0.327 
 
35 
51 
 
117 
133 
Mode of Delivery 
NVD 
Cesarean 
 
0.077 
 
 
72 
14 
 
186 
64 
Education 
<Diploma 
>Diploma 
 
0.019 
 
74 
12 
 
235 
15 
Job 
Housewife 
Employee 
 
0.778 
 
46 
40 
 
127 
123 
Sex of Neonate 
Male 
Female 
0.016 3542.3±398.4 3390.8±532.3 Weight of Neonate (Gram) 
 
 
0.001 
 
- 
78 
8 
 
5 
236 
9 
Weight of Neonate (gr)  
<2500 
2500-4000 
>4000 
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parity, gravidity, neonatal weight, and maternal 
occupation. The results of t-test, to compare the mean values 
of TG, cholesterol, LDL, HDL, LDL-C/HDL-C ratio, 
TG/LDL-C ratio, and TG/HDL-C ratio between the two 
groups of women with and without GDM based on GTT, 
showed significant differences between the two groups in 
TG, HDL, LDL-C/HDL-C ratio, TG/LDL-C ratio, and 
TG/HDL-C ratio (table 2). 
 
Table 2. Differences in serum lipid concentration between the groups with and without gestational diabetes mellitus (GDM) 
P value With GDM 
N=250 
Without GDM 
N=87 
Variables 
0.001 275.43± 69.33 205.53± 72.51 Triglyceride(TG)(mg/dl) 
0.705 228.82± 41.10 234.41± 132.01 Cholesterol  (mg/dl) 
0.956 122.82±31.47 122.57±43.35 Low density lipoprotein (LDL) 
0.001 53.30±14.88 66.28±25.78 High density lipoprotein (HDL) 
0.001 2.41 ±0.85 1.98±0.70 LDL/HDL 
0.001 2.38±0.87 1.85±1.10 TG/ LDL 
0.001 5.37±1.56 3.38±1.54 TG/ HDL 
 
The ROC curves for serum lipids level and lipids ratio in 
the third trimester of pregnancy associated with GTT and 
LGS were calculated to compare the accuracy of these 
variables.  
Table 3 shows the sensitivity, specificity, LR
+
, LR
-
 and 
odds ratio (OR) estimated for serum lipids level and lipids 
ratio in GTT and LGA at the optimal identified cutoff value 
for each method. As shown in table 3 and figure 1A, in the 
analysis of the ROC curve, the appropriate cut-off point for 
TG regarding the dependent variable GTT was ~235, at 
which sensitivity was 72.09% and specificity was 71.6%,  
 
 
and the area under curve (AUC) ROC was 0.769. For LGA, 
the cutoff point for LDL-C was ~138, at which sensitivity 
was 53.33% and specificity was 71.38%, and AUC ROC 
curve was 0.582 (figure 1C).The results of the logistic 
regression analysis for TG, cholesterol, LDL-C, and HDL-C 
for GTT and LGA showed that TG had a significant 
relationship with the dependent variable GDM, based on 
GTT, with an OR of 1.01 (p<0.001). The regression analysis 
performed in this study revealed that none of the lipid 
parameters were helpful in predicting the incidence of LGA 
(table 4). 
Table 3.Optimal cutoff points of maternal third-trimester lipids level and lipids ratio for predicting pregnancy outcomes 
Result AUC(95 % CI) Sensitivity 
% 
Specificity 
% 
Correctly sorted 
% 
LR+ 
% 
LR- 
% 
Cut off 
% 
Variables 
GTT 
Macrosomia 
0.769 
0.514 
72.09 
52.94 
71.60 
47.65 
72.92 
47.92 
2.53 
1.01 
0.39 
0.98 
235 
205 
Triglyceride 
GTT 
Macrosomia 
0.516 
0.562 
51.81 
64.71 
51.85 
53.40 
51.84 
53.99 
1.07 
1.38 
0.92 
0.66 
229 
230 
Cholesterol 
 
GTT 
Macrosomia 
0.480 
0.582 
48.05 
53.33 
49.56 
71.38 
47.2 
70.53 
0.90 
1.86 
1.11 
0.65 
120 
138 
LDL 
GTT 
Macrosomia 
0.266 
0.427 
32.56 
47.06 
34.80 
45.77 
34.23 
45.83 
0.49 
0.86 
1.93 
1.15 
59 
60 
HDL 
 
Table 4. The relationship between pregnancy complications and maternal serum lipid concentrations in the third trimester 
Triglyceride Cholesterol LDL HDL Variables 
AOR 
95 % CI 
p AOR 
95 % CI 
p AOR 
95 % CI 
p AOR 
95 % CI 
p 
1.01 (1.009-1.018) 0.0009 1.00 (0.998-1.003) 0.426 1.00 (0.995-1.02) 0.398 0.93( 0.042-1.803) 0.179 GTT 
1.00(.0992-0.971 0.987 0.99 (0.989-1.008) 0.893 1.01 (0.997-1.029) 0.092 0.98 ( 0.945-1.021) 0.378 Macrosomia 
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Fig 1: ROC Curve for TG (A), TG/LDL (B), LDL/HDL (C), TG-HDL (D) variables based on GTT test 
 
Discussion 
The results of this survey on comparison of maternal and 
neonatal variables between pregnant mothers with and 
without GDM showed significant differences between the 
groups in terms of TG, HDL-C, LDL-C/HDL-C ratio, 
TG/LDL-C ratio, and TG/HDL-C ratio. Similar to the results 
of our study, various studies have confirmed the association 
of dyslipidemia in pregnancies complicated with gestational 
diabetes (22-24). In the present study, the cut-off point 
(AUC ROC) with the use of GTT for TG was ~235, for 
LDL-C was ~138, and for TG/HDL-C ratio was 4.254, with 
a sensitivity of 79.07% and specificity of 78%.  
There are contradictory reports on lipid concentrations 
and ratios in GDM compared to women with healthy 
pregnancies. Dos Santos-Weiss et al. reported TG/HDL-C  
ratio as a predictor of GDM with a sensitivity of 82.6% and 
specificity of 83.4% at the cut-off point of 0.099  
(25), which is consistent to the results of our study, although 
the values are different that may be attributable to 
differences in diet, lifestyle and social conditions of the 
investigated participants. Wang et al. reported that TG/HDL-
C ratio, in conjunction with HbA1c and pre-pregnancy BMI, 
can predict the risk of GDM (13), which is in line with the  
results of the present study. The second studied outcome in  
 
 
this study included LGA, and regression analysis performed 
in this study revealed that none of the lipid parameters were 
helpful in predicting the incidence of LGA, while Wang et 
al. reported that TG/HDL-C ratio, in conjunction with 
HbA1c and pre-pregnancy BMI, can predict the risk of LGA 
(13), and  Mosayebi et al. found that maternal FBS and TG 
levels are independent factors for predicting neonatal weight 
and LGA (26), which contradict the results of the present 
study.  
In another study, Sacks et al. showed the association of 
TG in women with GDM with neonatal weight after 
adjustment for gestational age (27) and Son et al. found that 
serum TG concentrations during pregnancy can determine 
the birth of LGA infants in women with gestational diabetes 
(17). The inconsistency between the results of the above-
mentioned studies with the present study can be attributed to 
the differences in characteristics of the study population 
including ethnicity and genetic profile, sample size and 
method of measuring lipid parameters, which significantly 
affect neonatal birth weight. Although various studies have 
confirmed the association of maternal obesity, weight gain 
during pregnancy and maternal FBS during pregnancy with 
neonatal LGA (28-30), the role of maternal hyperlipidemia 
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in neonatal development is not yet fully understood. In the 
present study, lipid parameters were higher in women with 
GDM. Consistent with the results of the present study, some 
researchers confirm the significant increase in serum 
increased lipid profile including concentrations of TG/HDL-
C and LDL-C/HDL-C ratios in mothers with GDM 
compared to healthy pregnancies (31, 32). In the present 
study, diagnosis of GDM by GTT and GCT showed 
increased lipid parameters, except for cholesterol and LDL-
C. Consistent with the results of our study, Korkmazer et al. 
found that women with GDM have higher triglyceride levels, 
while their cholesterol and LDL-C levels are not different 
from healthy women’s (33), but Lopez-Tinoco et al. found 
no significant differences between the two groups in terms of 
serum HDL-C, TC and LDL-C levels, while TG was 
significantly higher in mothers with GDM (34), and Saucedo 
et al. showed that TG levels of women with GDM at 24-28 
weeks of gestation were significantly higher than women 
with healthy pregnancies, while no significant differences 
were observed between the two groups in terms of total 
cholesterol (35).  
These contradictory results could be attributed to the 
differences in ethnicity of participants. Moreover, others 
report no significant differences in serum concentrations of 
TG, TC, LDL-C, HDL-C and TG/HDL-C ratios between 
women with and without GDM (36-38). Special attention 
should be paid to the fact that assessment and interpretation 
of laboratory parameters during pregnancy is a complicated 
issue because of the changing levels of various hormones 
and several metabolic changes, aimed to improve fetal access 
to nutrition and other factors, which may be impaired or 
exacerbated in cases with GDM (25). For the same reason, 
serum tests performed at different trimesters could result in 
such differences among studies. 
The study limitations: The limitations of this study include 
the failure to assess the effect of factors such as maternal 
obesity and weight gain during pregnancy on the incidence 
of LGA. Moreover, as lipid profile alters in different weeks 
of gestation, future studies are recommended to assess the 
relationship between maternal lipid profile and GDM and 
LGA at different weeks of gestation. 
In conclusion according to the results, TG/HDL-C ratio 
plays a role in the incidence of GDM and the lipid profile 
can help predict the risk of GDM, but it cannot help predict 
the birth of neonate with LGA. The present study also 
determined the cutoff point for the TG/HDL-C ratio, by 
GTT, with a sensitivity of 79.07% and specificity of 78%. 
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